article thumbnail

Valcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations

Cannabis Law Report

COPENHAGEN , June 22, 2021 /PRNewswire/ — Valcon Medical A/S (“Valcon Medical” or the “Company”), Denmark’s leading independent cannabis concentrate and medical formulation provider, received its licensing for the commercial production of cannabis from the Danish Medicines Agency (DKMA) earlier in May 2021.

article thumbnail

MediPharm Labs Enters United States Pharmaceutical Market with Submission of FDA DMF

Cannabis Law Report

(TSX: LABS) (OTCQX: MEDIF ) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed a US FDA DMF for pure natural CBD API. The DMF will enable MediPharm to supply approved API to pharmaceutical companies currently conducting late-stage research.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

However, there are indications from studies done with cannabidiol-rich cannabis extracts in Israel that indicate that less side effects (46%) are achieved with a natural cannabis plant extract containing a 20:1 ratio of CBD to THC. Introduction: Recently, a formulation of cannabidiol was approved by the United States FDA.

article thumbnail

Avicanna Completes First Commercial Export of Aureus™ Branded THC Extracts to Austria and Welcomes Colombian Government’s Progressive New Regulation on Cannabis

Cannabis Law Report

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. Initial shipment of THC extracts into the European Union.

article thumbnail

Nextleaf Focused on Owning The Largest Patent Portfolio for the Extraction, Distillation, and Delivery of Cannabinoids

Cannabis Law Report

CSE: OILS) (OTCMKTS: OILFF) announced that it was granted its 15th patent from The United States Patent and Trademark Office for the extraction and purification of THC and CBD on June 23. At its extraction refinery in Vancouver, more than a half-ton of cannabis biomass can be processed into oil every day. cannabis patents to date.

article thumbnail

The Cannabis Cancer Connection

Project CBD

United Kingdom-based GW Pharmaceuticals has produced the world’s first approved cannabis-based medicines for the UK, US, and European markets, Sativex® and Epidiolex®. GW Pharmaceuticals’ research on glioblastoma multiforme (GBM) is important and promising. Note: In May 2021, GW Pharmaceuticals was acquired by Jazz Pharmaceuticals.]

article thumbnail

Clever Leaves has announced that it has launched its direct-to-business sales platform, Clever Leaves 360, for pharmceutical-grade cannabis extract products.

Cannabis Law Report

Clever Leaves , a leading multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, has now launched its new direct-to-business sales platform which offers pharmaceutical-grade cannabis extracts and finished products fit for a broad range of industries.